Are Analysts Bullish about Spire Healthcare Group Plc (LON:SPI) after last week?

February 14, 2018 - By Darrin Black

Spire Healthcare Group Plc (LON:SPI) Ratings Coverage

Among 11 analysts covering Spire Healthcare Group (LON:SPI), 5 have Buy rating, 1 Sell and 5 Hold. Therefore 45% are positive. Spire Healthcare Group has GBX 460 highest and GBX 234 lowest target. GBX 324.09’s average target is 46.78% above currents GBX 220.8 stock price. Spire Healthcare Group had 115 analyst reports since July 23, 2015 according to SRatingsIntel. As per Friday, March 10, the company rating was maintained by JP Morgan. The firm earned “Buy” rating on Friday, May 26 by Liberum Capital. JP Morgan downgraded it to “Neutral” rating and GBX 310 target in Thursday, November 12 report. JP Morgan maintained Spire Healthcare Group Plc (LON:SPI) rating on Friday, July 15. JP Morgan has “Neutral” rating and GBX 433 target. The stock of Spire Healthcare Group Plc (LON:SPI) has “Underperform” rating given on Friday, July 21 by Credit Suisse. The company was maintained on Friday, August 26 by Barclays Capital. The rating was maintained by Liberum Capital with “Buy” on Tuesday, June 13. Jefferies maintained the shares of SPI in report on Friday, January 8 with “Hold” rating. The firm has “Buy” rating given on Friday, February 12 by Berenberg. The rating was maintained by Berenberg on Wednesday, June 21 with “Buy”. Below is a list of Spire Healthcare Group Plc (LON:SPI) latest ratings and price target changes.

The stock decreased 1.43% or GBX 3.2 during the last trading session, reaching GBX 220.8. About 78,113 shares traded. Spire Healthcare Group Plc (LON:SPI) has 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. The company has market cap of 885.59 million GBP. It provides a range of integrated surgical, medical, and diagnostic services. It has a 33.45 P/E ratio. The firm offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgeries, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat problems; and eye surgery and treatments, family planning, foreign visa medical exams, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart diseases, and kidney disorders.

More news for Spire Healthcare Group Plc (LON:SPI) were recently published by: Ft.com, which released: “Spire Healthcare profits hit by settlement over botched surgery” on September 14, 2017. Ft.com‘s article titled: “Spire Healthcare lifted on news of £1.2bn Mediclinic offer” and published on October 23, 2017 is yet another important article.